Company Filing History:

5 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2007-2011

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8017624 - Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes (2011-09-13),

2. 7943615 - Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes (2011-05-17),

3. 7750034 - Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2010-07-06),

4. 7718667 - Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2010-05-18),

5. 7687492 - 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2010-03-30),

6. 7456204 - Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2008-11-25),

7. 7332520 - Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2008-02-19),

8. 7157490 - Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes (2007-01-02),

Title: Inventor Anthony Mastracchio: A Pioneer in Diabetes Treatment Innovations

Introduction

Anthony Mastracchio is an accomplished inventor based in Princeton, NJ, known for his significant contributions to medical science. With a remarkable portfolio of eight patents, he has played a pivotal role in advancing treatments for conditions related to diabetes by focusing on the innovative design of pharmaceutical compounds.

Latest Patents

Mastracchio's recent work includes two notable patents that address diabetes management through innovative chemical compounds. His inventions feature fused aminopiperidines as dipeptidyl peptidase-IV inhibitors, specifically targeting the enzyme involved in Type 2 diabetes. These novel substituted compounds not only inhibit the dipeptidyl peptidase-IV enzyme but also promise to provide therapeutic advances in the prevention and treatment of diabetes. The inventions also encompass pharmaceutical compositions designed for effective application in clinical settings.

Career Highlights

Throughout his career, Mastracchio has worked with prestigious organizations such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these renowned pharmaceutical companies has aided in refining his research and development skills, allowing him to focus on creating solutions that impact public health positively.

Collaborations

Collaboration has been a cornerstone of Mastracchio's successful career. He has worked alongside esteemed colleagues such as Scott D. Edmondson and Jason M. Cox. These collaborations have enriched his projects with diverse insights and expertise, fostering an environment of creative problem-solving within the realm of diabetes research.

Conclusion

Anthony Mastracchio stands as a testament to innovation in the field of diabetes treatment. With his eight patents and collaborations with leading pharmaceutical companies and professionals, he continues to make significant contributions that may one day lead to transformative therapies for diabetes, helping to improve the quality of life for millions around the world.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

5 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.